Cancer Biomarkers Market Predicted To Garner USD 67.1 Bn By 2032, At CAGR 11.2% | Exclusive Report By Marketresearch.Biz
Marketresearch.biz reports that the Cancer Biomarkers Market size is expected to be worth around USD 67.1 Bn by 2032 from USD 23.9 Bn in 2022, growing at a CAGR of 11.2% during the forecast period from 2023 to 2032. Overview of the Cancer Biomarkers Market The Cancer Biomarkers Market focuses on identifying specific molecules or genetic alterations associated with cancer, aiding in early detection, diagnosis, prognosis, and treatment selection. Biomarkers play a crucial role in personalized medicine, guiding targeted therapies and monitoring treatment response. This market segment encompasses a wide range of biomarker assays and technologies, driving advancements in precision…
- Date: March 22, 2024
- Author: Rohan Gadekar
- Category: PharmiWeb